Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021
/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced...
Source: prnewswire.com